Table:
begin	end	state
1	6	cytoplasmic
7	28	transmembrane
29	33	non-cytoplasmic
34	59	transmembrane
60	84	cytoplasmic
85	111	transmembrane
112	116	non-cytoplasmic
117	138	transmembrane
139	149	cytoplasmic
150	172	transmembrane
173	193	non-cytoplasmic
194	216	transmembrane
217	231	cytoplasmic
232	254	transmembrane
255	280	non-cytoplasmic
281	302	transmembrane
303	324	cytoplasmic
325	344	transmembrane
345	349	non-cytoplasmic
350	370	transmembrane
371	389	cytoplasmic
390	409	transmembrane
410	414	non-cytoplasmic
415	436	transmembrane
437	482	cytoplasmic

Input:
>WP_012102377.1 NCBI__GCF_000016505.1:WP_012102377.1
MEKKHKGLSVLQLTMMALGTIIGGSFFLGSSVAIHALGPFIIISYVLGGILVYFILSALS
EMTVADPSPGSFFTFTRKAFGSRAGFTVGWVYWTGMVLAMSSEAAAVSILIRRWFPGISI
SFLGSIIIIIITLLNLLGADKLSKLESGLAAVKLLAVVSFIIMALLLITGLLRLNTGAVD
VKGVKLSFLLPGGIKSIAGSMLTVMFAYAGFEIIGLAASETDNPKETIPRAIKYTVLSLV
ILYIASIYAVLLLIPTDILGENVSPMVAALNRWGMNWTGNVINIVMVIAILSTMLAAMFG
IGRMIRSLADEAYAPRWLKDNTNIPYKGMAFSGAAMFLGLMLGLLFPRVYLFLVSCGGFS
LLFTYVMIVASQIRMRKNHVYVIEKKQYSYISWITVISLIVIILSMPFIPGQASGLIAGI
IIIAFYSAAYTIMKYYIKIKKHGELKDKFNAKERKTGFLMELSKEFIERRKVFKRDKKKY
DK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server